Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Self-healing hydrogels loaded with selenium nanoparticles/chitosan/cellulose nanofibers as carriers of mesenchymal stem cells for diabetic wound healing.

Bi J., Wang H., Luo H., Qian C., Zhou J., Li X.

Animal Study on Diabetic Foot, Chronic Wound, Chronic Inflammation, published in Int J Biol Macromol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Int J Biol Macromol (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
40846001
DOI
10.1016/j.ijbiomac.2025.146905
Citations
3

Abstract (original English)

As one of the most serious chronic complications of diabetes mellitus, diabetic foot ulcers (DFUs) have a complex pathogenesis involving multiple factors such as persistent hyperglycemia-induced microangiopathy, chronic inflammatory state and oxidative stress injury. Regenerative medicine strategies of stem cells have brought new hope for DFUs treatment, among which adipose-derived mesenchymal stem cells (ADSCs) have attracted much attention due to their easy accessibility, multidirectional differentiation potential and paracrine function. However, excessive accumulation of reactive oxygen species (ROS) due to the high-glucose microenvironment can trigger mitochondrial dysfunction and premature senescence of ADSCs, which greatly reduce their therapeutic efficacy. To address this critical issue, this study innovatively constructed a Selenium nanoparticles/Chitosan/Cellulose nanofibers (SeNPs@CS-CNFs) self-healing hydrogel system. The hydrogel integrates: antimicrobial and epidermal regeneration benefits of chitosan; the three-dimensional porous network structure formed by cellulose nanofibers, and reduction-synthesized SeNPs scavenge ROS by GPX-mimicking activity. Its self-healing ability ensures structural stability during wound healing. In vitro, the SeNPs@CS-CNFs@ADSCs hydrogel significantly enhanced cell migration. In vivo experiments showed that SeNPs@CS-CNFs@ADSCs hydrogel

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
ChitosanWound HealingAnimalsHydrogelsCelluloseMesenchymal Stem CellsSeleniumNanofibersRatsNanoparticles

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research